Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

333
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
333
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

426
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
426
Censoring Survival Data01:09

Censoring Survival Data

689
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
689
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

596
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
596
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

727
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
727
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

888
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
888

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating the quality of tabular synthetic data in health care.

PLOS digital health·2026
Same author

Selecting medical research data platforms for translational biomedical research: a five-tier overview and requirement-weighted assessment framework.

Frontiers in digital health·2026
Same author

Data Quality in the ProVal-MS Study: Challenges and Lessons Learned.

Studies in health technology and informatics·2026
Same author

Scaling Electronic Consent for Research Integrated into Clinical Routine Processes.

Studies in health technology and informatics·2026
Same author

Accurate Yet Privacy-Preserving Determination of Case Numbers Across German University Hospital Health Data.

Studies in health technology and informatics·2026
Same author

A FHIR-Based Dashboard as an Integrated Research Patient Record and Quality Assurance Tool.

Studies in health technology and informatics·2026

Related Experiment Video

Updated: May 4, 2026

Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community
08:53

Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community

Published on: May 31, 2019

5.8K

A flexible approach to distributed data anonymization.

Florian Kohlmayer1, Fabian Prasser1, Claudia Eckert2

  • 1Technische Universität München, University Medical Center (MRI), Ismaninger Strasse 22, 81675 München, Germany.

Journal of Biomedical Informatics
|December 17, 2013
PubMed
Summary

This study introduces a flexible privacy-preserving method for anonymizing distributed biomedical data using secure multi-party computing (SMC). The approach supports various anonymization algorithms, enhancing data re-use and research sharing while maintaining data utility.

Keywords:
AnonymizationCommutative encryptionDistributionPersonal data protectionPrivacySMCSecure multi-party computing

Related Experiment Videos

Last Updated: May 4, 2026

Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community
08:53

Integrating Computerized Linguistic and Social Network Analyses to Capture Addiction Recovery Capital in an Online Community

Published on: May 31, 2019

5.8K

Area of Science:

  • Biomedical Informatics
  • Data Privacy
  • Secure Computation

Background:

  • Sensitive biomedical data is often fragmented across distributed systems, necessitating privacy-preserving integration.
  • Local autonomy and legal constraints demand robust anonymization for data re-use and sharing.

Purpose of the Study:

  • To present a flexible and privacy-preserving solution for anonymizing distributed biomedical datasets.
  • To enable secure data integration and sharing while adhering to privacy regulations.

Main Methods:

  • Utilized secure multi-party computing (SMC) to construct an encrypted global view of distributed data.
  • Developed a flexible framework supporting pre- and postprocessing for diverse anonymization algorithms and privacy criteria.
  • Implemented k-anonymity, ℓ-diversity, t-closeness, and δ-presence with a globally optimal de-identification method.

Main Results:

  • The proposed method demonstrated highly competitive performance in both analytical and experimental evaluations.
  • The prototype successfully handled horizontally and vertically distributed data setups.
  • The approach proved practical and flexible for a broad spectrum of anonymization needs.

Conclusions:

  • The developed solution offers a practical and flexible approach to anonymizing distributed biomedical data.
  • The method facilitates secure data sharing and re-use, crucial for advancing biomedical research.
  • The framework's adaptability supports various privacy criteria and anonymization algorithms.